Meanwhile, K-M survival analysis (Figs. 5B-C) indicated that elevated HMGN1 expression was linked to worse DSS results in ACC (p=0.009), KICH (p=0.034), KIRC (p<0.001), MESO (p=0.007), LIHC (p=0.006), PCPG (p=0.014), and SARC (p=0.006) patients. This evidence concerns the gene HMGN1 and adrenal cortex carcinoma.